Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy follows a carefully designed dose escalation schedule that helps your body adjust while building toward sustainable weight loss results. Clinical trials show that reaching therapeutic dosing levels—typically 2.4 mg weekly—produces meaningful reductions in body weight over 68 weeks of treatment. PlexusDx makes this journey accessible with compounded semaglutide injections starting at $149 per month, flat pricing regardless of your current dose level.
How Semaglutide Dosing Works for Weight Loss
Semaglutide dosing does not begin at maximum strength. Instead, patients start at a low dose—typically 0.25 mg weekly—and increase gradually every four weeks over a 16-week period. This step-wise approach reduces nausea, vomiting, and gastrointestinal side effects that commonly occur when patients receive higher doses immediately. Each dose increase gives your body time to adapt to how semaglutide affects appetite, satiety signaling, and food preferences.
The standard dose escalation ladder moves from 0.25 mg to 0.5 mg, then 1.0 mg, 1.7 mg, and finally 2.4 mg weekly. Most patients experience the strongest appetite reduction and weight loss at the 2.4 mg dose, which is where clinical trial data shows peak efficacy. However, some individuals feel well-controlled at lower maintenance doses like 1.7 mg weekly, while others may benefit from staying at intermediate levels based on their response and tolerability.
Understanding Therapeutic Dosing and Weight Loss Outcomes
Clinical research demonstrates that patients reaching semaglutide's higher dose ranges achieve greater weight reduction compared to those at lower doses. In the STEP 1 trial, patients on 2.4 mg weekly lost an average of 14% of baseline body weight over 68 weeks, compared to 2.6% in the placebo group. Importantly, weight loss continued even after the 16-week dose escalation ended, showing that therapeutic dosing produces sustained metabolic improvements rather than temporary appetite suppression.
Your path to maximum dosing depends on how well you tolerate each level and how your body responds. Some patients reach full therapeutic dose without difficulty, while others need to remain at 1.7 mg or lower if side effects become problematic. PlexusDx works with you to find the right dose for your situation, recognizing that 'maximum' for one person may differ from another's optimal maintenance level. The goal is sustainable weight loss, not reaching the highest dose possible.
Semaglutide vs. Tirzepatide: Different Dosing Strategies
While semaglutide targets the GLP-1 receptor alone, tirzepatide is a dual GLP-1 and GIP receptor agonist that may achieve weight loss effects at lower absolute doses. Tirzepatide's dose range goes from 2.5 mg to a maximum of 15 mg weekly, and some patients report stronger appetite reduction earlier in titration with tirzepatide than with semaglutide. This difference reflects tirzepatide's dual mechanism rather than superiority—both medications are highly effective when used at therapeutically appropriate levels.
Choosing between semaglutide and tirzepatide depends on your medical history, genetic response patterns, cost preferences, and how your body tolerates GLP-1 vs. dual-action therapy. PlexusDx offers both medications as compounded injections, with semaglutide starting at $149 monthly and tirzepatide at $249 monthly, so you can select the option that aligns with your clinical needs and budget without membership fees or insurance requirements.
Flat Pricing Means Your Costs Stay Stable as Your Dose Increases
PlexusDx charges one flat monthly rate for semaglutide injections regardless of whether you are at 0.25 mg or 2.4 mg weekly. This pricing structure removes financial barriers to dose escalation—you never face higher bills as your provider increases your medication strength during the titration phase. Starting at $149 per month means you have budget certainty from your first injection through your maximum therapeutic dose.
All PlexusDx medications come from licensed 503A compounding pharmacies, are available in all 50 states without insurance, and are HSA/FSA eligible. If you want additional insight into how your genes influence peptide receptor sensitivity and metabolic pathways, the optional Precision Peptide Genetic Test ($99 after your first treatment month) maps 14 pathways and 49 peptides—including variants in GLP1R, GIPR, FTO, and MC4R—to help personalize your long-term treatment approach.
Managing Side Effects During Dose Escalation
Nausea peaks during the first 1–2 weeks after a dose increase, then typically resolves as your body adapts. Slowing food intake, eating smaller portions, avoiding fatty foods, and staying hydrated help most patients move through each dose level comfortably. If side effects remain severe, your PlexusDx provider may slow the escalation schedule, extend the time between dose increases, or recommend staying at a lower maintenance dose that still delivers meaningful weight loss.
Constipation is another common adjustment—increasing fiber intake, drinking more water, and gentle movement support normal bowel function during semaglutide therapy. Rare but serious side effects include acute pancreatitis, thyroid issues, and gallbladder problems; these require immediate medical attention. PlexusDx providers screen for contraindications and monitor your progress, ensuring your dose increases align with your individual health profile and treatment goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the maximum semaglutide dose for weight loss?
The maximum semaglutide dose approved for weight loss is 2.4 mg injected once weekly. This dose is reached after 16 weeks of gradual escalation starting from 0.25 mg. Some patients achieve excellent results at lower maintenance doses like 1.7 mg, so your provider will help determine the right level for your body and goals.
How much weight can I expect to lose on semaglutide?
Clinical trial data shows patients on 2.4 mg semaglutide lost an average of 14% of their baseline body weight over 68 weeks. Weight loss varies by individual and depends on dose tolerance, adherence, diet, exercise, and genetics. PlexusDx's optional Precision Peptide Genetic Test can reveal how your GLP1R and other metabolic variants may influence your response.
Why does PlexusDx charge flat pricing instead of charging more for higher doses?
PlexusDx believes cost should never prevent patients from reaching their optimal therapeutic dose. By charging one flat rate—$149 monthly for semaglutide—whether you start at 0.25 mg or reach 2.4 mg, we remove the financial penalty for dose increases. Your dose may need to go up. Your price won't.
Are PlexusDx compounded medications as safe as brand-name semaglutide?
PlexusDx sources all medications from licensed 503A compounding pharmacies, which must meet strict FDA quality standards for purity, potency, and sterility. While compounded medications are not FDA-approved like brand names, 503A pharmacies operate under federal oversight and state pharmacy boards. Your PlexusDx provider reviews your medical history before dispensing to ensure safety.
Can the Precision Peptide Genetic Test predict if I'll respond well to semaglutide?
The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways affecting appetite, glucose metabolism, and weight regulation. A favorable GLP1R variant may suggest stronger receptor sensitivity, potentially predicting better semaglutide response. The test costs $99 after your first month of treatment and provides personalized insights across 150+ genetic markers related to peptide therapy success.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding the Costs of Wegovy for Weight Loss
Ozempic and Weight Loss: Can It Work Without Dieting?